Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
China · Delayed Price · Currency is CNY 13.60
-0.13 (-0.95%)
Feb 13, 2026, 3:00 PM CST
Shenzhen YHLO Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jan '21 Jan 1, 2021 |
Net Income | 143.32 | 301.53 | 355.01 | 1,012 | 204.75 | 210.53 |
Depreciation & Amortization | 245.03 | 245.03 | 197 | 144.73 | 99.32 | 69.5 |
Other Amortization | 11.2 | 11.2 | 13.57 | 29.91 | 5.21 | 4.23 |
Loss (Gain) From Sale of Assets | -1.82 | -1.82 | -2.79 | 3.39 | 0.2 | 0.02 |
Asset Writedown & Restructuring Costs | 9.71 | 9.71 | 9.8 | 10.33 | - | 1.25 |
Loss (Gain) From Sale of Investments | 31.52 | 31.52 | -85.35 | -59.84 | 2.82 | -0.19 |
Provision & Write-off of Bad Debts | 10.58 | 10.58 | 7.84 | 11.07 | 2.6 | 1.95 |
Other Operating Activities | -95.62 | -0.91 | -11.8 | 114.83 | 26.53 | 22.96 |
Change in Accounts Receivable | -130.55 | -130.55 | 12.93 | -190.33 | -54.96 | -58.25 |
Change in Inventory | 5.8 | 5.8 | -101.71 | -340.52 | -67.37 | -20.87 |
Change in Accounts Payable | 33.01 | 33.01 | -477.25 | 843.34 | 43.78 | 45.42 |
Change in Other Net Operating Assets | 15.64 | 15.64 | 13.49 | 21.41 | - | - |
Operating Cash Flow | 276.97 | 529.9 | -73.19 | 1,583 | 259.62 | 282.16 |
Operating Cash Flow Growth | -62.30% | - | - | 509.80% | -7.99% | 312.87% |
Capital Expenditures | -201.42 | -593.31 | -662.71 | -565.37 | -372.66 | -189.39 |
Sale of Property, Plant & Equipment | 0.04 | 0.02 | 0.06 | 0.03 | - | 0.21 |
Cash Acquisitions | - | -0.03 | - | -6.3 | - | - |
Divestitures | - | - | -21.57 | - | - | - |
Investment in Securities | 60.75 | -160.71 | 22.25 | -280.48 | -91.68 | - |
Other Investing Activities | 26.97 | 5.5 | 27.1 | -17.71 | 3.27 | 21.43 |
Investing Cash Flow | -113.67 | -748.52 | -634.88 | -869.83 | -461.08 | -167.76 |
Long-Term Debt Issued | - | 572.41 | 530.09 | 683.38 | 367.96 | 660 |
Long-Term Debt Repaid | - | -232.6 | -287.69 | -449.87 | -454.13 | -629.72 |
Net Debt Issued (Repaid) | 51.75 | 339.81 | 242.4 | 233.51 | -86.17 | 30.28 |
Issuance of Common Stock | 10.71 | 21.11 | 17.26 | - | 561.76 | - |
Common Dividends Paid | -140.63 | -169.03 | -282.53 | -169 | -10.9 | -36.23 |
Other Financing Activities | -1.58 | -11.17 | 3.61 | -51.03 | -17.15 | -2.81 |
Financing Cash Flow | -79.75 | 180.71 | -19.26 | 13.47 | 447.55 | -8.76 |
Foreign Exchange Rate Adjustments | -2.17 | -6 | 3.98 | 10.25 | -1.41 | -2.61 |
Net Cash Flow | 81.39 | -43.92 | -723.34 | 737.05 | 244.68 | 103.03 |
Free Cash Flow | 75.54 | -63.41 | -735.9 | 1,018 | -113.04 | 92.76 |
Free Cash Flow Margin | 3.97% | -3.15% | -35.84% | 25.57% | -9.60% | 9.29% |
Free Cash Flow Per Share | 0.14 | -0.11 | -1.28 | 1.79 | -0.21 | 0.18 |
Cash Income Tax Paid | 117.9 | 107.31 | 145.81 | 234.29 | 80.03 | 52.74 |
Levered Free Cash Flow | 93.37 | -203.3 | -943.74 | 855.65 | -122.11 | -10.51 |
Unlevered Free Cash Flow | 104.88 | -195.68 | -939.83 | 860.91 | -115.1 | -2.27 |
Change in Working Capital | -76.95 | -76.95 | -556.47 | 316.61 | -81.8 | -28.09 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.